Carolina Urologic Research Center

Carolina Urologic Research Center Carolina Urologic Research Center (CURC), is a separate and independent research arm of Grand Strand

Carolina Urologic Research Center (CURC) has been recognized both nationally and internationally as one of the most progressive, and respected clinical research sites in the United States. CURC employs a highly skilled and group of healthcare professionals, including 5 board-certified urologists, and 7 full time research coordinators. Over the last decade, we have participated in over 200 national and international clinical research trials for patients with various urologic conditions. Our areas of specialty include but are not limited to, prostate cancer, bladder cancer, renal cell carcinoma, overactive bladder, BPH (enlarged non-cancerous prostate), erectile dysfunction, kidney stones, and urinary tract infections, urinary incontinence as well as blood and biomarker studies. Our mission at Carolina Urologic Research Center is to provide cutting edge urologic treatments and therapies to our patients, especially when tradional standards of care have been exhausted. We believe that groundbreaking advances in healthcare are made possible by conducting quality clinical research trials. We are very proud of the service we provide, and are driven by the desire to improve and enrich the lives of our patients. We are grateful to the many participants and their families who have contributed to this effort

05/20/2025
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive B...
05/01/2025

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

Neal Shore, M.D., FACS, Medical Director for START Carolina Research Center, and lead investigator for the CREST trial.

This pivotal CREST trial data was presented at AUA meeting on April 26, 2025.
https://carolinaurologicresearchcenter.com/pfizers-sasanlimab-combination-significantly-improves-event-free-survival-in-bcg-naive-high-risk-non-muscle-invasive-bladder-cancer/

Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer T...
02/11/2025

Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
Authors: Neal D. Shore, MD & others (full author list in link)

https://carolinaurologicresearchcenter.com/expert-consensus-recommendations-on-the-management-of-treatment-emergent-adverse-events-among-men-with-prostate-cancer-taking-poly-adp-ribose-polymerase-inhibitor-novel-hormonal-therapy-combination/

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time I...
12/24/2024

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
Authors: Neal Shore, MD , Sarah M. Nielsen, MS , Edward D. Esplin, MD, PhD, Emmanuel S. Antonarakis, MD, Pedro C. Barata, MD, Tomasz M. Beer, MD, Himisha Beltran, MD, Alan Bryce, MD, Michael S. Cookson, MD, E. David Crawford, MD, Tanya B. Dorff, MD, Daniel J. George, MD, Elisabeth I. Heath, MD, Brian T. Helfand, MD, PhD, Maha Hussain, MD, Rana R. Mckay, MD, Alicia K. Morgans, MD, MPH, Michael J. Morris, MD, Channing J. Paller, MD, Ashley E. Ross, MD, PhD, Oliver Sartor, MD, John Shen, MD, Paul Sieber, MD, Matthew R. Smith, MD, PhD, David R. Wise, MD, PhD, Andrew J. Armstrong, MD

Authors: Neal Shore, MD , Sarah M. Nielsen, MS , Edward D. Esplin, MD, PhD, Emmanuel S. Antonarakis, MD, Pedro C. Barata, MD, Tomasz M. Beer, MD, Himisha Beltran, MD, Alan Bryce, MD, Michael S. Cookson, MD, E. David Crawford, MD, Tanya B. Dorff, MD, Daniel J. George, MD, Elisabeth I. Heath, MD, Bria...

In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?Authors: Jason R. Brown, MD...
12/17/2024

In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?
Authors: Jason R. Brown, MD, PhD, Neal D. Shore, MD, FACS, Pedro C. Barata, MD, MSc
Please click link to read entire article

Authors: Jason R. Brown, MD, PhD (University Hospitals Seidman Cancer Center, Cleveland, Ohio / Case Comprehensive Cancer Center, Cleveland, Ohio) Neal Shore, MD (Carolina Urologic Research Center, Myrtle Beach, South Carolina) Pedro C. Barata, MD, MSc (University Hospitals Seidman Cancer Center, Cl...

Address

823 82nd Pkwy
Myrtle Beach, SC
29572

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18438391679

Website

Alerts

Be the first to know and let us send you an email when Carolina Urologic Research Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Carolina Urologic Research Center:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

); }) .always(function() { gettingMore = false; }); } map._clearMarkers = function() { markersLayer.clearLayers(); } }); }, 4000); });